Paper36090686
Restorative effects of Rg3-enriched Korean Red Ginseng and Persicaria tinctoria extract on oxazolone-induced ulcerative colitis in mice.
Ullah HMA and 8 others. J Ginseng Res, 2022. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Restorative effects of Rg3-enriched Korean Red Ginseng and Persicaria tinctoria extract on oxazolone-induced ulcerative colitis in mice. Papers, record 36090686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36090686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Restorative effects of Rg3-enriched Korean Red Ginseng and Persicaria tinctoria extract on oxazolone-induced ulcerative colitis in mice.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28938606 | Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. | Oncotarget | 2017 | https://conductscience.org/library/papers/28938606 | PubMed |
| 2 | 25199861 | Ulcerative colitis: epidemiology, diagnosis, and management. | Mayo Clin Proc | 2014 | https://conductscience.org/library/papers/25199861 | PubMed |
| 3 | 20442201 | Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. | Gut | 2010 | https://conductscience.org/library/papers/20442201 | PubMed |
| 4 | 29243243 | Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/29243243 | PubMed |
| 5 | 25242194 | Evaluation of antinociceptive, in-vivo & in-vitro anti-inflammatory activity of ethanolic extract of Curcuma zedoaria rhizome. | BMC Complement Altern Med | 2014 | https://conductscience.org/library/papers/25242194 | PubMed |
| 6 | 33182623 | Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria. | Molecules | 2020 | https://conductscience.org/library/papers/33182623 | PubMed |
| 7 | 27278299 | Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27278299 | PubMed |
| 8 | 29475099 | Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Involvement of NF-κB and MAPK signalling pathways. | Int Immunopharmacol | 2018 | https://conductscience.org/library/papers/29475099 | PubMed |
| 9 | 23085552 | 3,3'-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction. | Mol Immunol | 2013 | https://conductscience.org/library/papers/23085552 | PubMed |
| 10 | 31561583 | Sertoli Cell Tumor (SCT) in a Captive Black Bear (Ursus americanus). | Vet Sci | 2019 | https://conductscience.org/library/papers/31561583 | PubMed |
| 11 | 33192127 | A novel herbal formulation consisting of red ginseng extract and Epimedium koreanum Nakai-attenuated dextran sulfate sodium-induced colitis in mice. | J Ginseng Res | 2020 | https://conductscience.org/library/papers/33192127 | PubMed |
| 12 | 9815270 | Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. | J Exp Med | 1998 | https://conductscience.org/library/papers/9815270 | PubMed |
| 13 | 28119098 | Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice. | J Ethnopharmacol | 2017 | https://conductscience.org/library/papers/28119098 | PubMed |
| 14 | 30405742 | Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis. | Evid Based Complement Alternat Med | 2018 | https://conductscience.org/library/papers/30405742 | PubMed |
| 15 | 27746697 | Korean Red Ginseng water extract arrests growth of xenografted lymphoma cells. | J Ginseng Res | 2016 | https://conductscience.org/library/papers/27746697 | PubMed |
| 16 | 29211811 | Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis. | PLoS One | 2017 | https://conductscience.org/library/papers/29211811 | PubMed |
| 17 | 24510619 | Dextran sulfate sodium (DSS)-induced colitis in mice. | Curr Protoc Immunol | 2014 | https://conductscience.org/library/papers/24510619 | PubMed |
| 18 | 31139644 | Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31139644 | PubMed |
| 19 | 28423560 | Geraniin attenuates LPS-induced acute lung injury via inhibiting NF-κB and activating Nrf2 signaling pathways. | Oncotarget | 2017 | https://conductscience.org/library/papers/28423560 | PubMed |
| 20 | 12433369 | Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. | Immunity | 2002 | https://conductscience.org/library/papers/12433369 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42662509 | Therapeutic potential of ginseng and its bioactive compounds in inflammatory bowel disease: current evidence and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42662509 | PubMed |
| 41550592 | Ginsenoside Rg3-enriched red ginseng extract mitigates sepsis by inhibiting platelet-leukocyte aggregates and regulates thrombo-inflammatory pathways. | J Ginseng Res | 2026 | https://conductscience.org/library/papers/41550592 | PubMed |
| 41339796 | Therapeutic effect of daucosterol on DSS-induced colitis in mice. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/41339796 | PubMed |
| 40741107 | Complementary medicines and ginseng for inflammatory bowel disease-rooted in science, but will it bear fruit? | World J Gastroenterol | 2025 | https://conductscience.org/library/papers/40741107 | PubMed |
| 40271055 | Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40271055 | PubMed |
| 39458575 | Inhibition of Angiogenesis and Effect on Inflammatory Bowel Disease of Ginsenoside Rg3-Loaded Thermosensitive Hydrogel. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39458575 | PubMed |
| 38698858 | Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system. | Front Immunol | 2024 | https://conductscience.org/library/papers/38698858 | PubMed |
| 38322531 | [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/38322531 | PubMed |
| 37902927 | Management of ulcerative colitis by dichloroacetate: Impact on NFATC1/NLRP3/IL1B signaling based on bioinformatics analysis combined with in vivo experimental verification. | Inflammopharmacology | 2024 | https://conductscience.org/library/papers/37902927 | PubMed |
| 36960868 | Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review). | Int J Mol Med | 2023 | https://conductscience.org/library/papers/36960868 | PubMed |
| 36656433 | Repressing effect of transformed ginsenoside Rg3-mix against LPS-induced inflammation in RAW264.7 macrophage cells. | J Genet Eng Biotechnol | 2023 | https://conductscience.org/library/papers/36656433 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL5 | 3567 | PubTator's text mining | https://conductscience.org/library/genes/3567 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MT-CO2 | 4513 | PubTator's text mining | https://conductscience.org/library/genes/4513 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| NOS2 | 4843 | PubTator's text mining | https://conductscience.org/library/genes/4843 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36090686
GET https://conductscience.org/api/papers/v1/36090686/references?page=2